Current Market Scenario:
The global Fc fusion protein market size reached USD 26.97 Billion in 2020 and is expected to register a significantly robust revenue CAGR during the forecast period, according to latest analysis by Emergen Research.
Some key factors expected to drive market revenue growth over the forecast period include increasing demand for Fc fusion proteins in non-clinical applications and rising prevalence of diabetes globally. Diabetes affects around 422 million people globally, the majority of whom live in low- and middle-income countries, and diabetes is directly responsible for 1.6 million fatalities per year. Over the last few decades, both the number of cases and the prevalence of diabetes have significantly increased, which is expected to boost demand for Fc fusion proteins, and in turn augment revenue growth of the market.
However, when Fc fusion protein is marketed or used in clinical trials, it is subject to stringent regulations, which is expected to limit the global Fc fusion protein market growth over the forecast period. Additionally, market revenue growth is expected to be limited to a certain extent by concerns regarding certain side effects of recombinant Eloctate with Fc fusion protein, which is used to treat hemophilia.
Claim Your FREE Sample Copy with Table of content@ https://www.emergenresearch.com/request-sample/816
Global Fc fusion protein market revenue is projected to expand at a CAGR of 10.5% and market size is expected to increase from USD 26.97 Billion in 2020 to USD 59.48 Billion in 2028. Market revenue growth is expected to be driven by rising demand for Fc fusion proteins in non-clinical applications and increased usage of Fc fusion proteins as drugs.
COVID-19 Impact Analysis:
The global distribution network was interrupted by the Covid-19 outbreak. The COVID 19 pandemic has adversely affected the primary healthcare systems around the world, causing activities related to routine vaccines to be disrupted and noncommunicable diseases to be neglected, among others. However, increasing research and development initiatives to develop effective coronavirus vaccines using Fc fusion protein are expected to boost market growth going ahead.
Current Trends and Innovations:
A significant factor expected to generate growth opportunities in the Fc fusion protein market in the near future is government initiatives to develop fusion protein biosimilars. The US Food and Drug Administration created the Biologics Price Competition and Innovations Act (BPCIA) to streamline the approval of biosimilar and interchangeable biopharmaceuticals, which is expected to provide additional chronic disease treatment options, improve accessibility to life-saving drugs, and potentially lower healthcare costs by competition.
Check Our Prices@ https://www.emergenresearch.com/select-license/816
The Asia Pacific Fc fusion proteins market revenue is expected to expand at a significantly robust CAGR over the forecast period, driven by rising awareness regarding the advantages of Fc fusion protein-based medicines in countries such as China, India, and Japan.
Some major companies operating in the market include Sanofi S.A., Bristol-Myers Squibb Company, Amgen Inc., Pfizer Inc., Swedish Orphan Biovitrum AB, Eli Lilly and Company, Astellas Pharma Inc., Bayer AG, Regeneron Pharmaceuticals, Inc., and 3SBio Inc.
- In July 2021, Amgen Inc. and Teneobio Inc. announced a deal in which Amgen would acquire Teneobio, which is a privately owned clinical-stage biotechnology firm focusing on a novel class of biologics known as Human Heavy-Chain Antibodies. Amgen’s capabilities to develop advanced medicine in treating patients with severe diseases and commercialize best-in-class products will be strengthened by the acquisition of Teneobio.
Emergen Research has segmented the global Fc Fusion Protein on the basis of type, therapeutic area, application, end-use, and region:
- Type Outlook (Revenue, USD Billion; 2018–2028)
- Biosimilar Drugs
- Brands Drugs
- Therapeutic Area Outlook (Revenue, USD Billion; 2018–2028)
- Eye Diseases
- Autoimmune Disease
- Application Outlook (Revenue, USD Billion; 2018–2028)
- In Vitro
- Flow Cytometry
- Binding Assays
- Microarray Technologies
- In Vivo
- Bio-therapeutic Drugs
- In Vitro
- End-Use Outlook (Revenue, USD Billion; 2018–2028)
- Ophthalmic Hospitals
- Oculoplastic Clinics
Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends: https://www.emergenresearch.com/industry-report/fc-fusion-protein-market#
- Regional Outlook (Revenue, USD Billion; 2018–2028)
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of APAC
- Latin America
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of MEA
- North America
Take a Look at our Related Reports:
Organ on a Chip Market By Type (Liver-on-Chip, Multiple Organs-on-Chips, Kidney-on-Chip, Heart-on-Chip, Lung-on-Chip, Intestine-on-Chip), By Application (Drug Discovery, Physiological Model Development, Toxicology Research), By End-Use (Pharmaceutical Firms, Research Institutes, Personal Care Industry), and By Region Forecast to 2028
Slide Stainers Market By Product (Reagents, Consumables & Accessories, Equipment), By Technology (Hematoxylin and Eosin, Immunohistochemistry, In Situ Hybridization, Cytology, Microbiology, Hematology, Special Stains), By End-Use (Hospitals and Diagnostic Centers, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Other), and By Region Forecast to 2028
2D Chromatography Market By Product (2D Gas Chromatography and 2D Liquid Chromatography), By Application (Life Science Research, Food and Beverage Testing, Environmental Analysis, Petrochemical and Natural Gas Analysis), By End-Use (Biotechnology and Pharmaceutical Sector, Hospitals, Ambulatory Surgery Centers, Cancer Research Laboratories, Agriculture and Food Industries, Specialty Clinics, Others), and By Region Forecast to 2028
Near-Infrared Imaging Market By Product Type (Devices, Reagents), By Application (Cancer Surgeries, Cardiovascular Surgeries, Gastrointestinal Surgeries, Reconstructive Surgeries, Preclinical Imaging), By End-use (Hospitals, Pharmaceutical Companies, Research Institutes), and By Region, Forecast to 2028
Contact Lenses Market By Usage (Daily Wear, Extended Wear, Traditional Lenses), By Design (Monovision, Spherical, Toric, Multifocal), By Material (Hybrid, Silicone Hydrogel, Rigid Gas Permeable, PMMA), By Application (Therapeutic, Lifestyle-Oriented, Prosthetic, Cosmetic, Corrective), By Marketing Channel (Online, Offline), and By Region
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
Read Full Press Release: https://www.emergenresearch.com/press-release/global-fc-fusion-protein-marke